Media & Press Kit

About Captario

At Captario, what we do can change the world.

Captario was founded on a mission to empower pharmaceutical businesses to make more proactive, fast, and insightful decisions. With a vision of revolutionizing pharma decision-making, Captario's focus has consistently been on developing our proprietary SaaS platform, Captario SUM®, supported by in-house scientific research on portfolio optimization to meet the goal of finding a more precise and straightforward solution to drug development modeling.

 

Through the Captario SUM® tool, our customers can:

  1. model a dependency-adjusted end-to-end drug development cycle;

  2. account for developmental uncertainty;

  3. access real-time insights across functional silos, and

  4. run countless what-if simulations in a sandbox environment that enables superior decision-making.
     

With more than 200 combined years of professional experience in the pharmaceutical space, our team saw first-hand how billion-dollar decisions lacked tool support that leverages modern technology and theory. We knew there had to be a better solution. When we couldn’t find one, we set out to build one instead.

 

At Captario, passion is in everything we do. Our principle is to make our customers successful, as their product is a solution or a cure for patients around the world. Our tools and services enable our customers to make the world better. Could a decision that our clients make with our simulations ultimately help thousands or even millions of people? How can we improve the development processes for picking life-changing solutions? That is how we at Captario can make a difference.

George Merck once said, ”We try never to forget that medicine is for the people.” At Captario, that statement could not be more accurate. For ten years, we have educated the pharma industry with the idea that pharma decision-making can be better. As pharmaceutical drug development processes are complex endeavors, we have to find a solution that caters to the many facets of drug discovery, guiding pharmaceutical companies to see the whole picture and, in the end, be able to advance more successful assets. At Captario, we have done just that. We know that the better we do, the better our global society can do.

 

We try never to forget that medicine is for the people, and our passion for that purpose fuels our product. The pharma industry needs change to meet the challenges of future drug development.

 

We are the change.

Captario Logos

Full Logo

Favicon Logo

Case Study PDF's

COVID-19 Portfolio Delay Scenarios

Evaluating Fast Track Opportunities

Clinical Trial Recruitment Impact on Market Order of Entry and Sales

NDA Submission Strategy

Quantitative Disease Area Strategy

Simulation-based Portfolio Forecasts

Scientific Research PDF's

A Modeling Framework For Improved Design & Decision-Making
in Drug Development

Multi-Objective Pharmaceutical Portfolio Optimization
under Uncertainty of Cost and Return

Pharmaceutical Portfolio Optimization under Cost Uncertainty
via Chance Constrained-Type Method

Selection Bias, Investment Decisions and Treatment
Effect Distributions

Do Strict Decision Criteria Hamper Productivity
in the Pharmaceutical Industry?

Project Moneyball: Quantifying the Benefits of Digital Biomarkers &
Technology-based Study Endpoints

Brand Video

Full Brand Video (3.39 Min)

Short Brand Video (40 Sec)

See Also

Press and Media Inquiries:

Oscar Hanson

oscar.hanson@captario.com